跳至主要内容
临床试验/NL-OMON52814
NL-OMON52814已完成2 期

Safety and preliminary efficacy of Alkaline Phosphatase in severely burned patients - Safety of AP in severe burns/ MAP4B

Rode Kruis Ziekenhuis0 个研究点目标入组 10 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • -partial/full thickness acute thermal burns of at least 15% TBSA
  • -Admission burn ICU
  • -Age >=18
  • -Written informed consent from patient or legal representative

排除标准

  • -Inclusion in another interventional clinical trial
  • -Patients who are pregnant or lactating
  • -Patients expected to have fatal disease within 24 hours
  • -Patients with chemical burns
  • -Patients who are having an known history of immune system that has been
  • impaired by disease, such as patients with HIV and with a CD4 count of less
  • than 200 cells/mm, neutropenic patients (<0.5 x 109/l) or medical treatment
  • with immunosuppressive effects
  • -Patients who have advanced chronic liver disease confirmed by a Child-Pugh C
  • -Patients with active haematological malignancy

研究者

发起方
Rode Kruis Ziekenhuis

相似试验